Latest market price
28.04
-0.82-2.84%
OverviewShort InterestFilings
AMLXQT90Amylyx Pharmaceuticals, Inc.·NASDAQ
28.04-2.84%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 07, 20264Statement of changes in beneficial ownership
Sep 14, 20264Statement of changes in beneficial ownership
Sep 14, 20264Statement of changes in beneficial ownership
Sep 14, 20264Statement of changes in beneficial ownership
Sep 14, 20264Statement of changes in beneficial ownership
Sep 14, 20264Statement of changes in beneficial ownership
Sep 08, 20268-KCurrent report
Sep 02, 20264Statement of changes in beneficial ownership
Aug 20, 20268-KCurrent report
Aug 20, 2026424B5Prospectus
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 18, 2026424B5Prospectus
Aug 18, 20268-KCurrent report
Aug 18, 20268-KCurrent report
Aug 06, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Jul 13, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
#1 / 25 of 378
Page
▼
/ 16